Japanese pharmaceutical company Takeda has chosen London as the site of its new four million pound European sales and marketing …
Hank McKinnell has stepped down as chief executive of Pfizer earlier than expected following continued criticism of his performance from …
Pfizer's new kidney cancer drug Sutent is rapidly catching up with its recently approved rival, Bayer's Nexavar.Sutent (sunitinib) has been …
Crestor was AstraZeneca's most rapidly expanding product in terms of European sales in the second quarter of this year. Sales …
Pfizer's potential blockbuster smoking cessation drug Champix has been recommended for European approval by a key EMEA committee.The first-in-class treatment …
AstraZeneca's blockbuster gastro-oesophageal reflux disease treatment Nexium has come out ahead of Wyeth's Zoton in a new study, which showed …
MDS Pharma Services has been named Europe's best provider of clinical research services in a survey of trial investigators.Conducted by …
The first-ever cervical cancer vaccine is set for approval in Europe following its recommendation from a key advisory committee.The positive …
Marrying traditional techniquesDespite researchers' natural leaning towards either qualitative or quantitative research, it is clear that the two types of …
A new organisation has been set up to give the medicines regulatory agency independent advice on how to improve patient …
David Nicholson, the current head of the health service in London has been named as the new NHS chief executive.With …
Wyeth's Enbrel has received a dual recommendation from NICE – guidance the pharma company hopes will influence healthcare decisions elsewhere …
Bayer has received the green light from European regulators for Nexavar to treat the most common type of kidney cancer …
Sanofi-Aventis breast cancer treatment Taxotere has been recommended by NICE in early breast cancer, giving it a boost over a …
A final decision from NICE on Roche's breast cancer treatment Herceptin is expected within five weeks, following a PCT appeal …
The number of attacks by animal rights extremists in the first six months of 2006 dropped sharply, building on improvements …
Healthcare communications agency Aurora has won a pan-European account to promote UCB Pharma's non-sedating prescription antihistamine Xyzal.The agency, based in …
The expert group set up by the MHRA in the wake of the disastrous Northwick Park clinical trial has made …
Novartis' new cancer drug will be submitted earlier than expected for European and US approval after showing positive results in …
The last few years have seen both dramatic and rapid changes in the adoption of interim management in the life …